On June 8, 2022, Oracle completed the acquisition of Cerner.
We help bring remarkable clarity to life sciences’ and healthcare’s most important decisions.
Why Cerner Enviza
Putting people’s health first means everything. It’s what drew us into this business in the first place –– to make a difference. Personally. Communally. Globally. To do that, we have to be collaborative in our efforts and united in our knowledge. We need to continue to break down industry silos as we move from simply accumulating and analyzing data to actively linking datasets. Generating deeper insights from multi-dimensional data can help find new medicines to improve people’s lives around the world.
Change starts by envisioning what’s possible. The ability to proactively accelerate therapy development and truly see insights across the full patient journey. The opportunity to offer research and trial opportunities for all health systems, all physicians –– all patients.
Because every patient is a person. And every person has a story.
What we do
Cerner Enviza ℠ leverages decades of life sciences expertise spanning commercial, real world, clinical and regulatory research and the broad range of Cerner provider networks and unique data sets to help accelerate the discovery, development and deployment of extraordinary insights and therapies to help transform healthcare and improve patients’ lives.
Cerner Enviza provides data-driven solutions and expertise that helps bring remarkable clarity to life sciences’ and healthcare’s most important decisions.